Status:
COMPLETED
Role of Computer-Aided Detection Colonoscopy in Polyp Detection Rate
Lead Sponsor:
Gian Eugenio Tontini
Collaborating Sponsors:
Pentax Medical
Conditions:
Colorectal Polyps
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
High-definition (HD) colonoscopy is the gold standard for early diagnosis and treatment of lower gastrointestinal neoplasms, with the adenoma detection rate (ADR) serving as a key quality indicator du...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age 40-80 years, any sex
- Indication for screening, surveillance, or diagnostic colonoscopy (e.g., anemia, abdominal symptoms)
- Written informed consent
- Exclusion criteria:
- Previous (even partial) colon resection or colonic stenosis
- Acute diverticulitis within 4 weeks
- Inflammatory bowel disease, familial adenomatous polyposis, or microscopic colitis
- Complete colonoscopy within 5 years
- Inadequate suspension of antithrombotic/antiplatelet therapy (per ESGE guidelines)
- Inability to provide consent
- Inadequate bowel preparation (Boston Bowel Preparation Scale \<2 in any segment)
Exclusion
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
421 Patients enrolled
Trial Details
Trial ID
NCT07171333
Start Date
August 1 2023
End Date
September 30 2024
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy